Definium Therapeutics DFTX
NASDAQ DFTX
$38.41 +2.24 (+6.19%)
At close: Sep 28, 2026 · 4:00 PM EDT

Definium Therapeutics (DFTX) Cash from Financing Activities (2021 - 2026)

Updated

Definium Therapeutics (DFTX) posted Cash from Financing Activities of $762.27 million for Q2 2026, compared with $19.65 million a year earlier.

Analysis

Definium Therapeutics (DFTX) Cash from Financing Activities (2021 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Cash from Financing Activities at Definium Therapeutics was $1.01 billion, up 981.1% year-over-year; for FY2025, it came in at $267.27 million, up 5.6% from FY2024.

  • Annual Cash from Financing Activities shows a five-year compound annual growth rate of 22.5% (FY2020 to FY2025).
  • In prior years, Definium Therapeutics' Cash from Financing Activities was $253.2 million in FY2024, $21.85 million in FY2023 (-63.0%), $59.05 million in FY2022 (-40.2%) and $98.82 million in FY2021 (+2.2%).
  • The Q2 2026 figure stands as the highest quarterly Cash from Financing Activities in data going back to Q1 2021.
  • On a year-over-year basis, Cash from Financing Activities increased in four of the last six quarters, with growth averaging 109.9%.
  • The strongest year-over-year quarter for Cash from Financing Activities in the past five years was Q2 2024, with growth of 746.8%; the weakest was Q1 2025, with a decline of 99.4%.
  • According to Business Quant data, Cash from Financing Activities for the three prior quarters was $5.31 million (Q1 2026), $245.87 million (Q4 2025) and $749,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn -8.78 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn -5.05 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn -47.00 Mn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn 2.34 Bn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn -426.70 Mn
10 Definium Therapeutics 4.00 Bn 4.00 Bn - 762.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 762.27 Mn
Mar 31, 2026 5.31 Mn
Dec 31, 2025 245.87 Mn
Sep 30, 2025 749,000.00
Jun 30, 2025 19.65 Mn
Mar 31, 2025 1.00 Mn
Dec 31, 2024 3.81 Mn
Sep 30, 2024 69.35 Mn
Jun 30, 2024 10.79 Mn
Mar 31, 2024 169.25 Mn
Dec 31, 2023 2.59 Mn
Sep 30, 2023 17.40 Mn
Jun 30, 2023 1.27 Mn
Mar 31, 2023 583,000.00
Dec 31, 2022 416,000.00
Sep 30, 2022 58.21 Mn
Jun 30, 2022 590,000.00
Mar 31, 2022 -166,000.00
Dec 31, 2021 127,000.00
Sep 30, 2021 820,000.00
API Access

Definium Therapeutics Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=DFTX&period=max&api_key=YOUR_API_KEY